Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.

Lokeshwar SD, Talukder A, Yates TJ, Hennig MJP, Garcia-Roig M, Lahorewala SS, Mullani NN, Klaassen Z, Kava BR, Manoharan M, Soloway MS, Lokeshwar VB.

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):464-472. doi: 10.1158/1055-9965.EPI-17-0700. Epub 2018 Feb 12.


Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.

Morera DS, Hennig MS, Talukder A, Lokeshwar SD, Wang J, Garcia-Roig M, Ortiz N, Yates TJ, Lopez LE, Kallifatidis G, Kramer MW, Jordan AR, Merseburger AS, Manoharan M, Soloway MS, Terris MK, Lokeshwar VB.

Br J Cancer. 2017 Nov 7;117(10):1507-1517. doi: 10.1038/bjc.2017.318. Epub 2017 Oct 3.


Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.

Jordan AR, Lokeshwar SD, Lopez LE, Hennig M, Chipollini J, Yates T, Hupe MC, Merseburger AS, Shiedlin A, Cerwinka WH, Liu K, Lokeshwar VB.

Oncotarget. 2017 Apr 11;8(15):24262-24274. doi: 10.18632/oncotarget.10529.


Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.

Yates TJ, Lopez LE, Lokeshwar SD, Ortiz N, Kallifatidis G, Jordan A, Hoye K, Altman N, Lokeshwar VB.

J Natl Cancer Inst. 2015 Apr 13;107(7). pii: djv085. doi: 10.1093/jnci/djv085. Print 2015 Jul.


Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Lokeshwar SD, Ruiz-Cordero R, Hupe MC, Jorda M, Soloway MS.

World J Urol. 2015 Dec;33(12):1929-36. doi: 10.1007/s00345-015-1548-x. Epub 2015 Apr 2.


Differential expression of SDF-1 isoforms in bladder cancer.

Gosalbez M, Hupe MC, Lokeshwar SD, Yates TJ, Shields J, Veerapen MK, Merseburger AS, Rosser CJ, Soloway MS, Lokeshwar VB.

J Urol. 2014 Jun;191(6):1899-1905. doi: 10.1016/j.juro.2013.11.053. Epub 2013 Nov 26.


Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods.

Iremashvili V, Lokeshwar SD, Jorda M, Pelaez L, Soloway MS.

J Urol. 2013 Jul;190(1):84-90. doi: 10.1016/j.juro.2012.12.021. Epub 2012 Dec 14.


Partial sampling of radical prostatectomy specimens: detection of positive margins and extraprostatic extension.

Iremashvili V, Lokeshwar SD, Soloway MS, Pelaez L, Umar SA, Manoharan M, Jordá M.

Am J Surg Pathol. 2013 Feb;37(2):219-25. doi: 10.1097/PAS.0b013e318268ccc1.


Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence.

Knapp JS, Lokeshwar SD, Vogel U, Hennenlotter J, Schwentner C, Kramer MW, Stenzl A, Merseburger AS.

World J Urol. 2013 Apr;31(2):351-8. doi: 10.1007/s00345-012-0925-y. Epub 2012 Aug 15.


C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.

Yates TJ, Knapp J, Gosalbez M, Lokeshwar SD, Gomez CS, Benitez A, Ekwenna OO, Young EE, Manoharan M, Lokeshwar VB.

Cancer. 2013 Jan 1;119(1):61-71. doi: 10.1002/cncr.27661. Epub 2012 Jun 26.


Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients.

Iremashvili V, Manoharan M, Lokeshwar SD, Rosenberg DL, Pan D, Soloway MS.

BJU Int. 2013 Mar;111(3):396-403. doi: 10.1111/j.1464-410X.2012.11295.x. Epub 2012 Jun 15.


Editorial comment to nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis.

Iremashvili V, Lokeshwar SD.

Int J Urol. 2012 Sep;19(9):853-4. doi: 10.1111/j.1442-2042.2012.03058.x. Epub 2012 May 22. No abstract available.


Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.

Kramer MW, Escudero DO, Lokeshwar SD, Golshani R, Ekwenna OO, Acosta K, Merseburger AS, Soloway M, Lokeshwar VB.

Cancer. 2011 Mar 15;117(6):1197-209. doi: 10.1002/cncr.25565. Epub 2010 Oct 19.


Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.

Lokeshwar VB, Lopez LE, Munoz D, Chi A, Shirodkar SP, Lokeshwar SD, Escudero DO, Dhir N, Altman N.

Cancer Res. 2010 Apr 1;70(7):2613-23. doi: 10.1158/0008-5472.CAN-09-3185. Epub 2010 Mar 23.

Supplemental Content

Loading ...
Support Center